We are a technology-based startup  developing medical devices for coronary arteries


Delawave's solution is a
coronary imaging catheter and system for CAD treatment

Approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan in March 2021

  • Intravascular Optical Coherence Tomography (OCT) catheter
  • OCT diagnostic imaging system
October, 2017
   Established in Kawaguchi-shi, Saitama
April, 2018   Relocation of office to Musashino-shi, Tokyo
May, 2019
   Obtainment of first-class marketing license for medical devices (Registration No. 13B1X10297)
May, 2019   Registration of Manufacturing Business (Registration No. 13BZ201298)
March, 2021   PMDA Approval
June, 2021   Reimbursement
New!! November, 2021 Became a family member of Genesis MedTech
March, 2021   PMDA Approval
Company Name Delawave, Inc.
Location 2-2-18-302 Sakai, Musashino-shi
Tokyo 180-0022 Japan
Founded October, 2017
Capital 10 Million JPY
Representative Director Kenji Taira
Sean Zhang
Capital 10 Million JPY
フォームから送信された内容はマイページの「フォーム」ボタンから確認できます。
Send